Andrew Dickinson
Vermögen: 23 Mio $ am 31.05.2026
Vermögen: 23 Mio $ am 31.05.2026
Herr Andrew D. Dickinson ist President, Treasurer & Director bei Immunomedics, Inc. sowie President, Treasurer & Director bei Forty Seven, Inc. und Chief Financial Officer bei Gilead Sciences, Inc. Er ist Mitglied des Board of Directors bei Immunomedics, Inc. und Forty Seven, Inc. sowie bei Fosun Kite Biotechnology Co., Ltd. und Gilead Sciences Ltd. Herr Dickinson war zuvor als Gründungspartner bei Kendall Dickinson & Koenig LLC, als Secretary, Vice President & General Counsel bei Myogen, Inc. und als Co-Head-Healthcare Investment Banking bei Lazard Ltd. tätig. Er erwarb seinen Bachelor-Abschluss an der University of Colorado und einen Master-Abschluss an der Loyola University of Chicago.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 171’646 ( 0.01% ) | 23 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GILEAD SCIENCES, INC. | Finanzdirektor/CFO | 01.11.2019 |
| FORTY SEVEN, INC. | Präsident | 07.04.2020 |
| CYMABAY THERAPEUTICS, INC. | Vorstandsvorsitzender | - |
Gilead Sciences Ltd.
Gilead Sciences Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Direktor/Vorstandsmitglied | 31.10.2019 |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Direktor/Vorstandsmitglied | - |
Sutter Health
Sutter Health Medical/Nursing ServicesHealth Services Operates as an online healthcare networking platform | Direktor/Vorstandsmitglied | 01.08.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Direktor/Vorstandsmitglied | 01.11.2025 |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cardiovascular diseases | General Counsel | 17.11.2006 |
| IMMUNOMEDICS, INC. | Präsident | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cardiovascular diseases | Health Technology |
Lazard, Inc.
Lazard, Inc. Investment Banks/BrokersFinance Provides financial advisory and asset management services | Finance |
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Kendall Dickinson & Koenig LLC
Kendall Dickinson & Koenig LLC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sutter Health
Sutter Health Medical/Nursing ServicesHealth Services Operates as an online healthcare networking platform | Health Services |
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Health Technology |
Gilead Sciences Ltd.
Gilead Sciences Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen